KDM2B-IN-3
KDM2B-IN-3 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 183c. KDM2B-IN-3 can be used for the research of cancer[1].
Product Specifications
CAS Number
[1966933-87-8]
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kdm2b-in-3.html
Solubility
10 mM in DMSO
Smiles
N#CCC1=C(OC)C=CC2=C1C=CC(C([C@@H]3[C@H](CCN(C4CCC4)C3)CC)=O)=C2
Molecular Formula
C25H30N2O2
Molecular Weight
390.52
References & Citations
[1]Albrecht BK, et, al. (piperidin-3-yl) (naphthalen-2-yl) methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer. WO2016112284A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139600/KDM2B-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139600/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
KDM2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
